Pharma Marketing News
PMN Home | Advertising Information | FAQs
About Us | Contact Us | Privacy Policy
Subscribe Glossary
Pharma Marketing Blog Pharmaguy Audio Podcasts Event Calendar PReader Surveys

Share |

Applying FDA Marketing Regulations to Internet Promotions
List of most commonly cited violations

At the recent CBI eMarketing for the Pharmaceutical Industry conference held in Philadelphia, PA, Preeti Pinto, M.S., Senior Director Promotional Regulatory Affairs, AstraZeneca, gave the attendees some insight on the regulatory actions taken by the FDA with respect to online DTC marketing by pharmaceutical companies. She summarized the most commonly cited violations found on pharmaceutical company web pages.

Topics covered include:

  • List of most commonly cited violations
  • Be Careful With Web Site Names
  • Online Clinical Trial Registries
  • Table: Pharmaceutical Website Marketing Violations

Read this article now. It's FREE...

Download PDF file

PMN43-05
Issue: Vol. 4, No. 3: March 2005
Word Count: 664

Find other articles in related Topic Areas:

Vol 4, #3 Contents










Contact Information
Editor
Pharma Marketing News

Pharma Marketing News | Subscribe | Industry Insights | Podcasts | Pharmaguy | Blog
Surveys | Glossary | Conference Calendar | Advertising Information | FAQs | About Us | Privacy Policy

© 2014. Pharma Marketing Network. All rights reserved.